Form 4 for ELAN Elanco Animal Health Inc
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0001415889-25-005169 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-19 | ELAN | Meer James M | CAO | A - Grant | $0.00 | +7,825 | 52.2K | +18% | $0 | |
| 2025-02-21 | 2025-02-19 | ELAN | Meer James M | CAO | F - Tax | $11.24 | -2,691 | 49.5K | -5% | -$30.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | A | A | 7,825 | $0.00 | 52,153 | D | — | — | (F1) The reporting person's Form 4 filed on March 6, 2023 inadvertently overstated the reporting person's direct Performance Stock Units by 4,445 shares. |
| 2 | Common | Common Stock | 2025-02-19 | F | D | 2,691 | $11.24 | 49,462 | D | — | — |